Life Scientist > Biotechnology

Metabolic gets good results on obesity drug

27 August, 2002 by Melissa Trudinger

Metabolic Pharmaceuticals has achieved another milestone in its development of a weight-loss drug after demonstrating that its obesity drug AOD 9604 is active after oral administration to human patients.


Investment feature: the world's a stage

27 August, 2002 by Pete Young

Drugs, vaccines, diagnostics and devices are the hotspots of the global biomedical market that Australia's biotech researchers are scrambling to fill with products.


ResMed launches lawsuit against competitor

27 August, 2002 by Pete Young

Sleep care company ResMed is living up to a reputation for aggressively defending its market position by launching a US patent infringement lawsuit against competitor Fisher and Paykel Healthcare.


Griffith has high hopes for patient monitor

26 August, 2002 by Claire Doble

Researchers at Griffith University have developed a new method that monitors patients' vital signs, and sends a message to doctors if there is a problem.


Genetic Solutions beefed up by BIF grant

23 August, 2002 by Pete Young

Agri-tech company Genetic Solutions will use a $250,000 Biotech Innovation Fund (BIF) grant to ride herd on a database holding more than one million samples of livestock DNA.


We've paid the price, now let us work: Amrad boss

23 August, 2002 by Melissa Trudinger

Gently suggesting that analysts and investors should back off and let Amrad focus on its product development, managing director Sandra Webb presented Amrad as a case study on maturing public biotechnology companies at the AusBiotech 2002 conference.


CSIRO aims to strengthen its biotech focus

22 August, 2002 by Melissa Trudinger

CSIRO has launched a biotechnology strategy in an attempt to strengthen its focus in the field.


Progen teams with CSIRO in manufacturing deal

20 August, 2002 by Pete Young

Australia's largest contract drug manufacturer, Progen Industries, and CSIRO are marrying their bio-manufacturing skills.


Contract research organisations: labs for hire

19 August, 2002 by Pete Young

As Australia's burgeoning young biotech hopefuls push toward clinical trials of their fledgling products, contract research organisations (CROs) are hoping for a rush of new business.


Cerylid appoints expat high-flyer to advisory board

19 August, 2002 by Iain Scott

Melbourne-based Cerylid Biosciences has appointed another internationally experienced scientist to its advisory board.


Eiffel pleased with micronised insulin study

19 August, 2002 by Melissa Trudinger

Melbourne-based Eiffel Technologies has announced that a pre-clinical study using micronised insulin demonstrated increased efficacy over native insulin.


Revenues expected, failures weren't, says Amrad boss

16 August, 2002 by Melissa Trudinger

Amrad released its end of financial year report on Friday, saying that revenues and expenses were in line with forecasts.


New appointments boost BioDiem team

16 August, 2002 by Iain Scott

Melbourne drug discovery company BioDiem has appointed two new executives as it gears up for a public listing.


Autogen means business with new appointment

16 August, 2002 by Melissa Trudinger

Victorian biotech Autogen has appointed a business development director whose role will be to spark new collaborations and capitalise on its IP.


Danes, Australians collaborate on 'handmade clones'

16 August, 2002 by Melissa Trudinger

Australian and Danish scientists have developed a breakthrough new technique to clone animals they term "handmade cloning."


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd